Drug news
Darbepoetin alfa-biosimilar Actorise launched in India for Anaemia-Cipla
Cipla has announced that it has collaborated with Hetero to launch a biosimilar of the drug darbepoetin alfa under the brand name Actorise, indicated for the treatment of Anaemia caused due to chronic kidney disease. The collaboration stands as a multi-partner co-marketing deal which offers Cipla a license to make the drug accessible to a wide number of patients in India. The product is available in pre-filled syringes (PFS) � 25 mcg and 40 mcg.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.